GPR-M 1 Tablet SR
Marketer
Astrodin Life Science Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview GPR-M 1 Tablet SR
Metformin/glimepiride extended-release tablets are classified as antidiabetic agents, combining two medications for adult type 2 diabetes management. This dual-action therapy helps regulate blood glucose. Administer this medication with food, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar; abrupt cessation can lead to elevated glucose, potentially causing kidney complications, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (sugary foods or juice) are essential to mitigate this risk. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring is necessary, along with potential blood tests to track blood cell counts and liver function.
Primary Ingredients of GPR-M 1 Tablet SR
No text was provided to rewrite.
Uses of GPR-M 1 Tablet SR
Managing type 2 diabetes
Major Benefits of GPR-M 1 Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The GPR-M 1 Tablet SR should be taken with a meal.
Common Side effects of GPR-M 1 Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use GPR-M 1 Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; avoid chewing, crushing, or breaking it. Consume GPR-M 1 Tablet SR with a meal.
How GPR-M 1 Tablet SR works:
GPR-M 1 SR Tablet merges glimepiride, a sulfonylurea, and metformin, a biguanide, to manage blood sugar. Glimepiride stimulates pancreatic insulin release, reducing blood glucose. Metformin acts triply: it diminishes hepatic glucose production, slows intestinal glucose uptake, and enhances insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol while taking GPR-M 1 Tablet SR.
PregnancyCONSULT YOUR DOCTOR
The use of GPR-M 1 Tablet SR during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. It's crucial to seek medical advice.
Breast feedingUNSAFE
Lactation and the sustained-release GPR-M 1 Tablet are incompatible. Evidence indicates potential infant harm from this medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when administering GPR-M 1 Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. GPR-M 1 Tablet SR is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.
LiverCAUTION
Exercise caution when administering GPR-M 1 Tablet SR to individuals with hepatic impairment. Dosage modification of GPR-M 1 Tablet SR may be necessary. Physician consultation is advised. For patients exhibiting mild to moderate liver dysfunction, GPR-M 1 Tablet SR is typically initiated at a reduced dosage; however, its use is contraindicated in cases of severe liver disease.
What if you forget to take GPR-M 1 Tablet SR :
Should you forget to take a GPR-M 1 Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About GPR-M 1 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |




